prostate cancer
Conditions
Interventions
Gold Standard:pathology
Index test:1.Primary observation indicator: Biopsy positive rate
2.Secondary observation indicators:
Procedure time for each group (local anesthesia time + prostate biopsy time),Targeted biopsy positi
Sponsors
Zhejiang Provincial Hospital of Traditional Chinese Medicine (First Affiliated Hospital of Zhejiang Chinese Medical University)
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1.PSA > 10 ng/ml; 2.PSA 4-10 ng/ml with abnormal f/t PSA or PSAD; 3.Suspicious prostate nodule detected on digital rectal examination; 4.Suspicious prostate lesions identified on TRUS, MRI, or PSMA PET/CT; 5.Patients who agree to participate in the study and provide informed consent.
Exclusion criteria
Exclusion criteria: 1.In the acute infection or febrile phase; 2.Dysfunction of vital organs such as the heart, lungs, or brain; 3.Use of anticoagulants, antiplatelet drugs, or a tendency to bleed; 4.Poorly controlled or unstable comorbid conditions such as hypertension or diabetes; 5.Severe internal or external hemorrhoids, perianal or rectal lesions; 6.Severe immunosuppressive state; 7.Severe psychological disorders or patients who are uncooperative with the procedure; 8.Patients unable to comply with the study protocol or follow-up requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biopsy positive rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Targeted biopsy positive rate;Procedure time for each group;Effective biopsy rate;Tissue sample length;Intraoperative blood loss;Incidence of complications;Patient pain score; | — |
Countries
China
Contacts
Public ContactJiasheng Yan
Zhejiang Provincial Hospital of Traditional Chinese Medicine (First Affiliated Hospital of Zhejiang Chinese Medical University)
Outcome results
None listed